Friday , May 26 2017
Breaking News
Home / Business / Caplin Point gets EIR from USFDA for sterile injectable plant in Tamil Nadu

Caplin Point gets EIR from USFDA for sterile injectable plant in Tamil Nadu

Caplin Point Laboratories has received the Establishment Inspection Report (EIR) from USFDA for the inspection carried out during October 21 – 27, 2016 at its sterile injectable plant at Gummidipoondi, Tamil Nadu. The facility, capable of manufacturing Liquid Injectables in Vials, Ampoules, Lyophilized Vials and Ophthalmic dosages, is also approved by EU-GMP and ANVISA-Brazil.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

About editor

Leave a Reply

Your email address will not be published. Required fields are marked *

*

Close